These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9888309)
1. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier. Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Mahato RI; Takemura S; Akamatsu K; Nishikawa M; Takakura Y; Hashida M Biochem Pharmacol; 1997 Mar; 53(6):887-95. PubMed ID: 9113108 [TBL] [Abstract][Full Text] [Related]
3. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery. Hirabayashi H; Nishikawa M; Takakura Y; Hashida M Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426 [TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. Nishikawa M; Takemura S; Takakura Y; Hashida M J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363 [TBL] [Abstract][Full Text] [Related]
5. Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice. Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M J Pharmacol Exp Ther; 1999 Sep; 290(3):1242-9. PubMed ID: 10454500 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice. Nishikawa M; Takemura S; Yamashita F; Takakura Y; Meijer DK; Hashida M; Swart PJ J Drug Target; 2000; 8(1):29-38. PubMed ID: 10761643 [TBL] [Abstract][Full Text] [Related]
7. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA. Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270 [TBL] [Abstract][Full Text] [Related]
8. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242 [TBL] [Abstract][Full Text] [Related]
9. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting. Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Takakura Y J Control Release; 1999 Nov; 62(1-2):253-62. PubMed ID: 10518658 [TBL] [Abstract][Full Text] [Related]
10. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. Katsumi H; Nishikawa M; Yasui H; Yamashita F; Hashida M J Control Release; 2009 Nov; 140(1):12-7. PubMed ID: 19646492 [TBL] [Abstract][Full Text] [Related]
11. Carbamylation decreases the cytotoxicity but not the drug-carrier properties of polylysines. Ekrami HM; Shen WC J Drug Target; 1995; 2(6):469-75. PubMed ID: 7773608 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Kawakami S; Wong J; Sato A; Hattori Y; Yamashita F; Hashida M Biochim Biophys Acta; 2000 Dec; 1524(2-3):258-65. PubMed ID: 11113576 [TBL] [Abstract][Full Text] [Related]
13. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. Choi YH; Liu F; Park JS; Kim SW Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). Hashida M; Takemura S; Nishikawa M; Takakura Y J Control Release; 1998 Apr; 53(1-3):301-10. PubMed ID: 9741938 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands. Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383 [TBL] [Abstract][Full Text] [Related]
16. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653 [TBL] [Abstract][Full Text] [Related]
17. [Comparative studies of different carriers and introducing routes on the effects of liver targeted uptake of exogenous gene]. Yang C; Wang J; Wen S; Liu J; Guo J Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):227-9. PubMed ID: 10951625 [TBL] [Abstract][Full Text] [Related]
18. Repression of GAD autoantigen expression in pancreas beta-Cells by delivery of antisense plasmid/PEG-g-PLL complex. Lee M; Han SO; Ko KS; Koh JJ; Park JS; Yoon JW; Kim SW Mol Ther; 2001 Oct; 4(4):339-46. PubMed ID: 11592837 [TBL] [Abstract][Full Text] [Related]
19. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification. Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045 [TBL] [Abstract][Full Text] [Related]
20. [Inhibition of HBV gene expression by antisense oligonucleotides using galactosylated poly (L-lysine) as a hepatotropic carrier]. Zhong S; Wen S; Zhang D Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):150-3. PubMed ID: 11436645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]